Fewer than 10 percent of patients in England who are eligible for Mounjaro will initially be able to access it on the health service, after officials revealed they are prioritising …
According to the latest NHS data, 64% of adults in England are classified as either overweight or obese. And with the NHS spending over £11bn a year to treat the …
Tragedy struck as Susan McGowan, a 58 year old NHS bed manager, died after taking two doses of the weight loss drug Mounjaro, which has been hailed as the “King …
A staggering 64% of adults in England are classed as either overweight or obese according to the most recent NHS figures. And with those numbers continuing to rise, interest in …
It was Boxing Day 2003, when after seven months on Orlistat, the wonder weight-loss drug of the early noughties, Moira was rushed to hospital. In her late 30s and weighing …
The drug tirzepatide, made popular for its treatment of Type 2 diabetes and weight loss, lowers the risk of progression to diabetes by 94 per cent among adults with prediabetes …
CLAYTON, N.C. (AP) — Novo Nordisk, the maker of Ozempic and Wegovy, announced on Monday that it plans to add 1,000 jobs when another company manufacturing plant is built in …
(The Hill) — A popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found. Tirzepatide, the medicine found in the drug …
A teenager who was left feeling suicidal due to his weight lost one stone using an Ozempic-style weightloss drug. As diabetes medicine Mounjaro, dubbed the “King Kong” of weight loss, …
Tirzepatide, also known by the brand name Mounjaro, mimics hormones which make you feel full. It is already available on the NHS to combat Type 2 diabetes. Medicines assessors will …